Neurocrine Biosciences Inc

Company Profile

Neurocrine Biosciences Inc had its IPO on 1996-05-23 under the ticker symbol NBIX.

The company operates in the LIFE SCIENCES sector and (NO DISGNOSTIC SUBSTANCES) industry. Neurocrine Biosciences Inc has a staff strength of 0 employees.

Stock update

Shares of Neurocrine Biosciences Inc opened at $119.3 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $118.71 - $125, and closed at $122.06.

This is a +2.26% increase from the previous day's closing price.

A total volume of 1,946,246 shares were traded at the close of the day’s session.

In the last one week, shares of Neurocrine Biosciences Inc have increased by +8.02%.

Neurocrine Biosciences Inc's Key Ratios

Neurocrine Biosciences Inc has a market cap of $11.674 billion, indicating a price to book ratio of 7.77 and a price to sales ratio of 8.61.

In the last 12-months Neurocrine Biosciences Inc’s revenue was $1.297 billion with a gross profit of $0.791 billion and an EBITDA of $0.179 billion. The EBITDA ratio measures Neurocrine Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Neurocrine Biosciences Inc’s operating margin was 0% while its return on assets stood at 5.25% with a return of equity of 0.9%.

In Q3, Neurocrine Biosciences Inc’s quarterly earnings growth was a negative -57.6% while revenue growth was a positive 30.9%.

Neurocrine Biosciences Inc’s PE and PEG Ratio

Forward PE

28.41

Trailing PE

938.92

PEG

1.87

Its diluted EPS in the last 12-months stands at $0.13 per share while it has a forward price to earnings multiple of 28.41 and a PEG multiple of 1.87. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Neurocrine Biosciences Inc’s profitability.

Neurocrine Biosciences Inc stock is trading at a EV to sales ratio of 8.23 and a EV to EBITDA ratio of 233.04. Its price to sales ratio in the trailing 12-months stood at 8.61.

Neurocrine Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Neurocrine Biosciences Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Neurocrine Biosciences Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Neurocrine Biosciences Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Neurocrine Biosciences Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Neurocrine Biosciences Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$122.06

52-Week High

$125

52-Week Low

$71.88

Analyst Target Price

$125.08

Neurocrine Biosciences Inc stock is currently trading at $122.06 per share. It touched a 52-week high of $125 and a 52-week low of $125. Analysts tracking the stock have a 12-month average target price of $125.08.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.